OCD Trial, Recruiting NCT05467683 Sponsor: Jasper A. Smits Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT05467683
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed (using a formal clinical interview) with one of the following as your main condition: panic disorder (with or without fear of open spaces), social anxiety disorder, generalized anxiety disorder, obsessive-compulsive disorder (OCD), or post-traumatic stress disorder (PTSD).
  • Your anxiety symptoms are rated at 8 or higher on a standard anxiety measurement scale, indicating a meaningful level of anxiety and impact on daily life.
  • You are between 18 and 70 years old.
  • You are willing and able to give your informed agreement to participate and follow the study's requirements.
  • You are fluent in English, as the assessment tools used in this study have only been tested and validated in English.

Who may not be able to join:

  • You have ever been diagnosed with bipolar disorder or a psychotic disorder, or you have had a substance use problem (not including tobacco/nicotine) or an eating disorder within the past 6 months, or you have significant memory or thinking difficulties.
  • You are currently having thoughts of suicide with some intention to act on them, or you have made a suicide attempt or taken preparatory steps toward suicide in the past 6 months.
  • You have certain medical conditions that make breathing exercises involving carbon dioxide or deliberate overbreathing unsafe — for example, irregular heartbeat, heart failure, asthma, lung scarring, high blood pressure, epilepsy, or a history of stroke.
  • You are currently pregnant or breastfeeding.
  • You are already receiving talk therapy (psychotherapy) aimed at treating your main anxiety condition.
  • You have started a new psychiatric medication within the 8 weeks before your screening appointment (if you have been on a stable medication regimen for longer than this, you may still be eligible).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jasper A. Smits
Registry
ClinicalTrials.gov
Start date
2 November 2022
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Non-response to exposure-based therapy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov